Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma

Clinical trial NCT01022918 · COMPLETED

Trial details

NCT number: NCT01022918
Sponsor: Centre Georges Francois Leclerc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Naive Unresectable Glioblastoma

Start date: 2009-01-01
Primary completion: 2010-07-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.